# Serranator® Alto Post Market Clinical Follow Up (PMCF) Study

> **NCT03538392** · — · WITHDRAWN · sponsor: **Cagent Vascular LLC**

## Conditions studied

- Peripheral Arterial Disease
- Arterio-venous Fistula
- Arteriovenous Graft

## Interventions

- **DEVICE:** Serranator® Alto

## Key facts

- **NCT ID:** NCT03538392
- **Lead sponsor:** Cagent Vascular LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Product not available, study withdrawn
- **Last updated:** 2020-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03538392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03538392, "Serranator® Alto Post Market Clinical Follow Up (PMCF) Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03538392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*